We also tested MINTIE on samples containing CBFB-MYH11 fusions, RUNX1-RUNX1T1 fusions and FLT3-ITDs known to be in the core binding factor (CBF) AML data [27], as well as a cohort containing KMT2A-PTDs [32], identified by Audemard et al. [33]. Here, FLT3 is linked to acute myeloid leukemia.